Skip to main content
. 2021 Nov 8;8(11):270. doi: 10.3390/vetsci8110270

Figure 1.

Figure 1

Superovulation treatments in the experiment. CIDR-B®, intravaginal device impregnated with 1.56 g progesterone. EB, 5 mg of estradiol-17β. FSH, 400 mg of follicle-stimulating hormone in eight decreasing doses. P4, 50 mg of progesterone. PGF, 25 mg of prostaglandin F. GnRH, 0.01 mg of Gonadotrophin-releasing hormone. FTAI, fixed time artificial insemination.d, day of superovulation treatment.